skip to Main Content

TRANSFORM-HF (ToRsemide compArisoN with furoSemide FOR Management of Heart Failure) Study

Patients with heart failure will be randomized 1:1 to either oral torsemide or oral furosemide prior to hospital discharge. The primary endpoint will be all-cause mortality over the follow-up period. Secondary endpoints are hospitalizations, quality of life, and depression.

Investigator: Ambrosy, Andrew

Funder: National Heart, Lung, and Blood Institute

Explore all studies and publications

Back To Top